Edesa Biotech Акции в обращении
Что обозначает Акции в обращении в Edesa Biotech?
Акции в обращении Edesa Biotech, Inc. является 18.154M
Какое определение для Акции в обращении?
Акции в обращении - это все акции корпорации или финансового актива, которые были разрешены, выпущены и приобретены инвесторами и находятся в их собственности.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Акции в обращении компаний в Health Care сектор на NASDAQ по сравнению с Edesa Biotech
Что делает Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Компании с акции в обращении похож на Edesa Biotech
- Zhongchao имеет Акции в обращении из 18.103M
- New Destiny Mining имеет Акции в обращении из 18.106M
- Gulfport имеет Акции в обращении из 18.107M
- Aptose Biosciences Inc имеет Акции в обращении из 18.109M
- Vigil Health Solutions имеет Акции в обращении из 18.128M
- Orca имеет Акции в обращении из 18.151M
- Edesa Biotech имеет Акции в обращении из 18.154M
- New Home Inc имеет Акции в обращении из 18.161M
- Career Point имеет Акции в обращении из 18.163M
- Phio Pharmaceuticals имеет Акции в обращении из 18.164M
- Vasta Platform имеет Акции в обращении из 18.169M
- Cosmo Films имеет Акции в обращении из 18.173M
- V-Mart Retail имеет Акции в обращении из 18.174M